Lynx Biosciences, Inc.

Lynx Biosciences, Inc. is a leading biotechnology research company dedicated to resolving cancer biology through integrated multi-omics. Located in San Diego, California at 3210 Merryfield Row, Lynx Biosciences is at the forefront of transforming translational research with patient-centric models.

Lynx Biosciences is reshaping translational and reverse translational research by combining patient-derived cell models, microphysiological systems (MPS), and integrated multi-omic analyses. This innovative approach generates clinically meaningful insights earlier and without reliance on animal models. The Lynx Biosciences platform supports high-content functional profiling of antibody and cell-based therapies in complex ex vivo co-cultures, preserving the native biology of the tumor and immune microenvironment.

As the field shifts toward more scalable, patient-centric approaches to drug development, Lynx Biosciences offers a solution built to meet this moment. Lynx Biosciences works across oncology and immunology indications to profile therapeutic activity in ex vivo models, integrate imaging, cytokine analysis, and transcriptomics from the same culture, identify predictive biomarkers, stratify responders, and uncover resistance mechanisms to guide target refinement. The approach of Lynx Biosciences enables the resolution of responder and non-responder profiles, mechanistic biomarkers, and functional signatures from limited clinical material, accelerating the development of novel biologics and cell-engaging therapies. Lynx Biosciences offers a plug-in, human-relevant platform to de-risk development, guide patient selection, and inform smarter, earlier decisions.

To the manager of Lynx Biosciences, we invite you to create a customized and exclusive company showcase and product listing on our platform.